26th March 2021
26th March 2021
Moderators: Graham Hughes (UK) Ricard Cervera (Spain)
APS/Hughes Syndrome – a personal history.
Graham Hughes (UK)
Lessons from CAPS registry.
Ricard Cervera (Spain)
Update on the New Antiphospholipid Syndrome Classification Criteria Development.
Stephane Zuily (France)
Moderators: Denis Wahl (France) Ljudmila Stojanovich (Serbia)
Antiphospholipid syndrome and direct oral anticoagulants.
Denis Wahl (France)
The cutaneous manifestations precede severe vascular: from the cross-section analysis of a national APS patients registry.
Ljudmila Stojanovich (Serbia)
Heart failure profile in autoimmune diseases – analysis of the Serbian antiphospholipid syndrome patients.
Aleksandra Djokovic et al. (Serbia)
Should be older patients tested for antiphospholipid antibodies? 695 cases from the retrospective HIBISCUS series.
Belizna Cristina on behalf of HIBISCUS working group (France, Argentina, Serbia, Belgium, Spain, Italy, Russian Federation)
The management of thrombocytopenia in patients with Primary Antiphospholipid Syndrome.
Laura Andreoli (Italy)
Platelets indices and treatment in antiphospholipid syndrome patients.
Natasa Stanisavljevic (Serbia)
Thrombocytopenia in antiphospholipid syndrome longitudinal follow-up.
Tatjana Reshetnyak (Russian Federation)
Moderators: Munther Khamashta (UAE), Vittorio Pengo (Italy)
New insight in APS pathogenesis: cue for new diagnostic/therapeutic approach?
Pier Luigi Meroni (Italy)
Recognition and meaning of Lupus Anticoagulant.
Vittorio Pengo (Italy)
Antiphospholipid antibodies negativisation in patients with antiphospholipid syndrome: a long-term follow-up multicenter study.
Massimo Radin (Italy)
Presence of immune complexes of IgG/IgM bound to B2-glycoprotein i in APS patients: report from a preliminary study to an international cohort.
Naranjo L.et al. (Spain, Serbia, Israel)
Molecular Profiling of Antiphospholipid Syndrome Patients: Type I Interferon Signature Heterogeneity among Disease Subsets.
Irene Cecchi (Italy)
Peptide Microarray based on R39-R43 of Domain I of β2-Glycoprotein I Determined Antigenic Specificity of Antiphospholipid antibodies.
Marc Moghbel et al (Italy, Switzerland)
Comparative analysis of different ELISA assays for determination of aPL antibodies.
Violeta Dopsaj (Serbia)
Targeting plasma cells: New APS therapy aimed to resetting humoral immune memory.
Antonio Serrano (Spain)
Anticardiolipin antibodies and Anti-beta 2 glycoprotien 1: a comparative analysis from two centres with added value of antiprothrombin antibodies.
Marija Atanaskovic Popovic et al. (Serbia, Slovenia)
Moderators: Shoenfeld Y (Israel), Wahl D (France)
Covid 19 the virus of autoimmunity –how it is related to APS?
Yehuda Shoenfeld (Israel)
APS and Covid-19, a critical review.
Denis Wahl (France)
Preliminary Estimation of the COVID-19 in Systemic Lupus and Other Rheumatic Disease: Therapeutics Response in Stable Disease Condition.
Ljudmila Stojanovich et al (Serbia)
β-2-Glycoprotein-I deficiency could precipitate an antiphospholipid syndrome-like in COVID-19 patients.
Manuel Serrano on behalf of APS-COVID 19 Study Group/European Forum on aPL. (Spain)
The Covid-19 vaccine aspect and thrombosis
Pier-Luigi Meroni, Wahl Denis, Marteen Limper
Moderators: Angela Tincani (Italy), Elisabet Svenungsson (Sweden), Marija Zdravkovic (Serbia)
The role of complement as predictor of adverse pregnancy outcome in obstetric APS.
Angela Tincani (Italy)
Complement deposition, C4d, on platelets is associated with vascular events and antiphospholipid antibodies in systemic lupus erythematosus.
Elisabet Svenungsson (Sweden)
aPL Prevalence in Women with Late Pregnancy Complication and Low-risk for Chromosomal Abnormalities
Silvia Foddai et al (Italy)
Thrombotic risk assessment in antiphospholipid syndrome using thrombin generation assay.
Barinotti A (Italy)
Cardiac MRI in patients with autoimmune rheumatic diseases.
Marija Zdravkovic (Serbia)
Early diagnosis of antiphospholipid syndrome in patients with subclinical manifestation -Radiology perspective.
Jovica Saponjski (Serbia)
Effects of CSF from CNS SLE patients on neuronal calcium signaling.
Milosevic M et al. (Serbia, Canada)